The persistence of neutralising antibodies up to 11 months after SARS CoV-2 infection in the southern region of New Zealand

N Z Med J. 2022 Feb 25;135(1550):162-166.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Neutralizing
  • COVID-19*
  • Humans
  • New Zealand / epidemiology
  • SARS-CoV-2
  • Severe Acute Respiratory Syndrome*

Substances

  • Antibodies, Neutralizing